Report copyright - TITLE: A Phase 1 Feasibility Study of Abraxane and ...dose-dense day 1, 8 of both paclitaxel (90 mg/m2) and carboplatin (AUC 4) administered every 21 days to 42 patients. The median
Please pass captcha verification before submit form